Stay updated on Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial page.

Latest updates to the Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe site footer now identifies the website as revision v3.8.0 instead of v3.7.2.SummaryDifference0.0%

- Check16 days agoChange DetectedAn NIH announcement explains that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and points readers to updates and FAQs.SummaryDifference0.2%

- Check23 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check30 days agoChange DetectedThe footer's site revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check51 days agoChange DetectedThe history now includes a new Revision: v3.7.0 and removes Revision: v3.6.6, updating the page's revision trail. This reflects an update to the page's versioning rather than substantive content changes to the study.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision: v3.6.6 appears on the page, replacing the previous v3.6.5. This indicates an updated build of the page’s interface and underlying systems.SummaryDifference0.0%

Stay in the know with updates to Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial page.